On December 6, 2022, the latest model of the self-developed ophthalmic optical coherence tomography (OCT) scanner by Big Vision Medical Technology, BV1000S, was successfully registered, becoming the newest member of Big Vision’s fully automatic artificial intelligence OCT product line.
Product advantages
Optical coherence tomography (OCT) is an important ophthalmic diagnostic tool that uses high-resolution and non-invasive imaging to visualize the microstructure of the retina, completely changing the way ophthalmic patients are examined and diagnosed, and has been widely used in ophthalmic clinics.
Since the launch of Big Vision Medical’s fully automatic artificial intelligence OCT, it has been welcomed by ophthalmic departments in various levels of hospitals for its excellent full-automatic operating experience and powerful diagnostic assistance function. It has played a positive role in the popularization and application of OCT equipment in grassroots medical institutions.
Big Vision Medical’s new product, the BV1000S, adopts a new generation of high-reliable full-automatic 3D motion platform technology. It combines excellent optical design, automated algorithms, parallel high-speed computing framework, and high-usabilityhuman-machine interactive interface to break through tradition, significantly improve image
Product features
More portable and user-friendly design
The fully automatic artificial intelligence OCT, which conforms to ergonomics, adopts an optical mainframe split design. The appearance design is more exquisite, the volume of the mainframe is smaller, making it easier to screen and transport, and more conducive to viewing the details of the fundus image.
Faster acquisition of fundus signals
Big Vision’s new generation of fully automatic artificial intelligence OCT, the BV1000S, has a faster scanning speed. The 80,000 times/second fast scanning helps to accurately capture the different subdivided forms of fundus lesions in a shorter time and obtain high-quality images.
Finer imaging of fundus structure
The BV1000S also integrates industry-leading ophthalmic AI algorithms, which can accurately identify and automatically annotate disease lesion areas. It can provide more valuable basis for doctors to develop treatment plans and bring a better experience for customers.
Build on past successes and continue to achieve more
Since its establishment, Big Vision Medical Technology has focused on the research and development, manufacturing of ophthalmic disease analysis and diagnostic systems, and is committed to becoming a globally top eye imaging diagnosis company. With artificial intelligence technology and internet model, it promotes the industrialization of advanced technology and effectively promotes the development of China’s ophthalmic equipment industry. At present, it has obtained more than 80 innovative achievements and patents, and has won honorary awards such as the first prize of the “Wu Wenjun Artificial Intelligence Technology Invention Award”.
Looking to the future, as a pioneer in ophthalmic imaging artificial intelligence analysis and diagnosis in China, Big Vision will gather momentum and make efforts to achieve more breakthroughs from “0 to 1”, effectively enhance its independent innovation capabilities, use technology for good, and bring benefits to the people by promoting visual health.
No comments yet.